Shinefield H - Search Results

1

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R. Shinefield H, et al. N Engl J Med. 2002 Feb 14;346(7):491-6. doi: 10.1056/NEJMoa011297. N Engl J Med. 2002. PMID: 11844850 Free article. Clinical Trial.

2

Impact of the pneumococcal conjugate vaccine on otitis media.

Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Fireman B, et al. Pediatr Infect Dis J. 2003 Jan;22(1):10-6. doi: 10.1097/00006454-200301000-00006. Pediatr Infect Dis J. 2003. PMID: 12544402 Clinical Trial.

3

Prevention of Staphylococcus aureus infections: advances in vaccine development.

Shinefield HR, Black S. Shinefield HR, et al. Expert Rev Vaccines. 2005 Oct;4(5):669-76. doi: 10.1586/14760584.4.5.669. Expert Rev Vaccines. 2005. PMID: 16221068 Review.

4

Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants.

Shinefield H, Black S, Ray P, Fireman B, Schwalbe J, Lewis E. Shinefield H, et al. Pediatr Infect Dis J. 2002 Mar;21(3):182-6. doi: 10.1097/00006454-200203000-00003. Pediatr Infect Dis J. 2002. PMID: 12005078 Clinical Trial.

5

Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California.

Black S, Shinefield H. Black S, et al. Among authors: shinefield h. Eur J Pediatr. 2002 Dec;161 Suppl 2:S127-31. doi: 10.1007/s00431-002-1064-z. Epub 2002 Nov 9. Eur J Pediatr. 2002. PMID: 12494258 Clinical Trial.

6

Efficacy of pneumococcal conjugate vaccines in large scale field trials.

Shinefield HR, Black S. Shinefield HR, et al. Pediatr Infect Dis J. 2000 Apr;19(4):394-7. doi: 10.1097/00006454-200004000-00036. Pediatr Infect Dis J. 2000. PMID: 10783042 Review.

7

Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine.

Ray GT, Butler JC, Black SB, Shinefield HR, Fireman BH, Lieu TA. Ray GT, et al. Among authors: shinefield hr. Pediatr Infect Dis J. 2002 May;21(5):361-5. doi: 10.1097/00006454-200205000-00002. Pediatr Infect Dis J. 2002. PMID: 12150168 Clinical Trial.

8

Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort.

Black SB, Lewis E, Shinefield HR, Fireman B, Ray P, DeStefano F, Chen R. Black SB, et al. Pediatr Infect Dis J. 2002 Jun;21(6):568-9. doi: 10.1097/00006454-200206000-00018. Pediatr Infect Dis J. 2002. PMID: 12182385

9

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, Noyes J, Lewis E, Ray P, Lee J, Hackell J. Black SB, et al. Pediatr Infect Dis J. 2002 Sep;21(9):810-5. doi: 10.1097/00006454-200209000-00005. Pediatr Infect Dis J. 2002. PMID: 12352800 Clinical Trial.

10

Pneumococcal conjugate vaccine in children.

Davis RL, Fireman B, Shinefield HR. Davis RL, et al. N Engl J Med. 2004 Jan 1;350(1):84-5; author reply 84-5. doi: 10.1056/NEJM200401013500117. N Engl J Med. 2004. PMID: 14702434 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page